Stock analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE stock opened at $0.32 on Monday. Ampio Pharmaceuticals has a fifty-two week low of $0.14 and a fifty-two week high of $8.30. The business’s 50 day moving average price is $1.19 and its two-hundred day moving average price is $1.87. The company has a market capitalization of $364,335.00, a price-to-earnings ratio of -0.03 and a beta of 1.95.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last posted its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 4/22 – 4/26
- Investing in the High PE Growth Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
